These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17653446)

  • 1. Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities Study.
    Vigo A; Duncan BB; Schmidt MI; Couper D; Heiss G; Pankow JS; Ballantyne CM
    Braz J Med Biol Res; 2007 Jul; 40(7):933-41. PubMed ID: 17653446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
    Huang G; Yin M; Xiang Y; Li X; Shen W; Luo S; Lin J; Xie Z; Zheng P; Zhou Z
    Diabetes Metab Res Rev; 2016 Sep; 32(6):615-22. PubMed ID: 26787598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
    Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
    Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti-glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme-linked immunosorbent assay.
    Takagi S; Miura J; Hoshina S; Uchigata Y; Babazono T
    J Diabetes Investig; 2020 Mar; 11(2):356-362. PubMed ID: 31267698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of age at diagnosis and duration of diabetes on the positivity of glutamic acid decarboxylase antibody in South-Brazilian type 1 diabetes mellitus.
    Maraschin Jde F; Weinert LS; Murussi N; Witter V; Rodrigues Tda C; Rossato ER; Silveiro SP
    Ann Clin Biochem; 2013 May; 50(Pt 3):262-6. PubMed ID: 23610212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.
    Littorin B; Sundkvist G; Hagopian W; Landin-Olsson M; Lernmark A; Ostman J; Arnqvist HJ; Blohmé G; Bolinder J; Eriksson JW; Lithner F; Scherstén B; Wibell L
    Diabetes Care; 1999 Mar; 22(3):409-12. PubMed ID: 10097919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
    Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
    Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
    Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
    J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating anti-glutamic acid decarboxylase-65 antibody titers are positively associated with the capacity of insulin secretion in acute-onset type 1 diabetes with short duration in a Japanese population.
    Yamamura S; Fukui T; Mori Y; Hayashi T; Yamamoto T; Ohara M; Fukase A; Sasamori H; Kobayashi T; Hirano T
    J Diabetes Investig; 2019 Nov; 10(6):1480-1489. PubMed ID: 30919585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
    Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of INS VNTR is associated with glutamic acid decarboxylase antibodies and postprandial C-peptide in patients with onset of diabetes after 35 years of age.
    Matejková-Behanová M; Vanková M; Hill M; Kucera P; Cinek O; Andel M; Bendlová B
    Physiol Res; 2004; 53(2):187-90. PubMed ID: 15046555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
    Arikan E; Sabuncu T; Ozer EM; Hatemi H
    J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.
    Kim CS; Nam JH; Nam JS; Park JS; Kang ES; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Metabolism; 2006 Aug; 55(8):1107-12. PubMed ID: 16839848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glutamic acid decarboxylase 65 immunoglobulin G subclass profile differs between adult-onset type 1 diabetes and latent autoimmune diabetes in adults (LADA) up to 3 years after clinical onset.
    Hillman M; Törn C; Landin-Olsson M;
    Clin Exp Immunol; 2009 Aug; 157(2):255-60. PubMed ID: 19604265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).
    Zampetti S; Campagna G; Tiberti C; Songini M; Arpi ML; De Simone G; Cossu E; Cocco L; Osborn J; Bosi E; Giorgino F; Spoletini M; Buzzetti R;
    Eur J Endocrinol; 2014 Dec; 171(6):697-704. PubMed ID: 25213702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
    Kawasaki E; Awata T; Ikegami H; Imagawa A; Oikawa Y; Osawa H; Katsuki T; Kanatsuna N; Kawamura R; Kozawa J; Kodani N; Kobayashi T; Shimada A; Shimoda M; Takahashi K; Chujo D; Tsujimoto T; Tsuchiya K; Terakawa A; Terasaki J; Nagasawa K; Noso S; Fukui T; Horie I; Yasuda K; Yasuda H; Yanai H; Hanafusa T; Kajio H;
    J Diabetes Investig; 2024 Jul; 15(7):835-842. PubMed ID: 38451108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
    Zampetti S; Capizzi M; Spoletini M; Campagna G; Leto G; Cipolloni L; Tiberti C; Bosi E; Falorni A; Buzzetti R;
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3759-65. PubMed ID: 22865904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2).
    Louraki M; Katsalouli M; Kanaka-Gantenbein C; Kafassi N; Critselis E; Kallinikou D; Tsentidis C; Karavanaki K
    Diabetes Res Clin Pract; 2016 Jul; 117():82-90. PubMed ID: 27329026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.